Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol TRIM32 contributors: mct/npt/pgu - updated : 27-11-2018
HGNC name tripartite motif-containing 32
HGNC id 16380
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart   highly
Digestiveintestinelarge intestinecolon  
Lymphoid/Immunespleen    
 thymus    
Nervousbrain   predominantly Homo sapiensTRIM32 RNA
 braindiencephalonhypothalamus  
Reproductivefemale systemuterus  highly
 male systemprostate   
 male systemtestis   
Skin/Tegumentskin   highly
Visualeye    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Muscularstriatumskeletal lowly Homo sapiensTRIM32 RNA
Muscularstriatumskeletal   Mus musculusAdult
cells
SystemCellPubmedSpeciesStageRna symbol
Muscularmyoblast Homo sapiensTRIM32 RNA
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period
Text TRIM32 mRNA expression is &
8764;16 times higher in myoblasts than in skeletal muscle tissue
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • an N-terminal RING zinc finger, necessary for the pro-apoptotic function of TRM32 as well as being responsible for its E3 ligase activity
  • a type 2 B-box domain
  • a coiled-coil domain (RBCC) so called tripartite motif (TRIM)
  • five NHL repeats
  • C-terminus forms a beta-propeller NHL domain
  • conjugated PhosphoP
    HOMOLOGY
    interspecies homolog to rattus Trim32 (96.9 pc)
    homolog to murine Trim32 (96.2 pc)
    Homologene
    FAMILY
  • C-VII TRIM family
  • TRIM/RBCC family
  • CATEGORY enzyme , protooncogene
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,cytosolic,granule
    intracellular,cytoplasm,cytoskeleton,microtubule
    intracellular,nucleus
    text
  • accumulated in cytoplasmic granules
  • localized to the Z-line in skeletal muscle
  • basic FUNCTION
  • playing a role in mediating biological activity of the HIV1-TAT protein (lentiviral tat protein)
  • having E3-ubiquitin-ligase activity, and playing a role in regulating components of the cytoskeleton
  • required for the localization of G protein-coupled receptors to primary cilia on central neurons
  • participating in myofibrillar protein turnover, especially during muscle adaptation
  • acting as a transcription coactivator
  • mediating the ubiquitination of ABI2
  • being a novel oncogene that promotes tumor growth, metastasis, and resistance to anticancer drugs
  • E3 ubiquitin ligase that binds to myosin and ubiquitinates actin
  • promotes PIAS4 ubiquitination and degradation, and by controlling PIAS4 stability, regulates UVB-induced keratinocyte apoptosis through induction of NFkappaB
  • regulator of dysbindin (the LGMD2H/STM mutations may impair substrate ubiquitination)
  • thought to be involved in protein ubiquitination, but its precise physiological role in muscle is unknown
  • sensitizes cells to TNF-induced apoptosis
  • has specific E3 ligase activity against XIAP and down-regulates XIAP through its RING domain-dependent E3 ligase activity
  • may act as a general sensitizer of various pro-apoptotic signals triggering either the intrinsic or the extrinsic pathway
  • functions as one of the co-activators for RARA-mediated transcription
  • during fasting, desmin phosphorylation increases and enhances TRIM32-mediated degradation of the desmin cytoskeleton, which appears to facilitate the breakdown of Z-bands and thin filaments
  • mutual regulation between TP73 and TRIM32 constitutes a novel feedback loop, which might have important implications in central nervous system development as well as relevance in oncogenesis
  • function of the cell fate-determinant TRIM32 for a balanced activity of the adult neurogenesis process
  • is a positive regulator of Asymmetric cell division (ACD) that acts against MYCN and should be considered as a tumor-suppressor candidate
  • regulates fate specification of neural stem cells
  • is a novel essential positive factor modulating axonal regeneration and the recovery of motor function following spinal cord injury (SCI), possibly through suppressing proliferation of glial cells
  • TRIM32 associates with the deubiquitination enzyme USP7, which previously has been implicated in neural stem cell maintenance, and exhibit a dynamic and partially overlapping expression pattern during neuronal differentiation
  • CELLULAR PROCESS cell life, differentiation
    nucleotide, transcription, regulation
    protein, ubiquitin dependent proteolysis
    PHYSIOLOGICAL PROCESS
    text
  • fat cell differentiation
  • PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule metal binding,
  • Zn2+
  • protein
  • maybe involved in protein-protein interaction, noteworthy lentiviral TAT protein through its NHL repeats
  • interacting with the head and neck region of myosin
  • E3 ubiquitin ligase that acts in conjunction with ubiquitin-conjugating enzymes UBCH5A, UBCH5C, and UBCH6
  • binding specifically to the activation domain of HIV-1 Tat
  • can also interact with the HIV-2 and EIAV Tat proteins in vivo
  • interaction of PIAS4 with TRIM32, an E3-ubiquitin ligase promotes PIAS4 degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB
  • binding to ABI2
  • binds and ubiquitinates DNBDD1, a protein implicated in the genetic aetiology of schizophrenia, augmenting its degradation)
  • binds and ubiquitinates dysbindin, a protein implicated in the genetic aetiology of schizophrenia, augmenting its degradation
  • interactions between TRIM32 and UBE2V2, and UBE2V1 (TRIM E3 activity is only manifest with the UBE2 with which they interact)
  • colocalizes and directly interacts with XIAP, a well known cancer therapeutic target, through its coiled-coil and NHL domains
  • interacts with RARA and enhances its transcriptional activity in the presence of RA
  • ubiquitin ligase TRIM32 controls myogenic differentiation process through the regulation of MYC, a similar mechanism to that previously observed in neural progenitors
  • interacted with TMEM173A, and was located at the mitochondria and endoplasmic reticulum
  • TRIM32, a new direct TP73 transcriptional target in the context of neural progenitor cells, is differentially regulated by TP73
  • TRIM32 interacted with MYCN at spindle poles during mitosis, facilitating proteasomal degradation of MYCN at spindle poles and inducing Asymmetric cell division (ACD)
  • TRIM32 interacts with TP53 and promotes TP53 degradation through ubiquitination
  • NDRG2 is a novel target for TRIM32 and TRIM32 is involved in control of myogenic cells proliferation and differentiation
  • TRIM32 associates with proteins involved in neurogenesis and RNA-related processes, such as the RNA helicase DDX6, which has been implicated in microRNA regulation
  • is essential for the induction of neuronal differentiation of neural stem cells by poly-ubiquitinating MYC to target it for degradation resulting in inhibition of cell proliferation
  • TRIM32 modulates pluripotency entry and exit by directly regulating POU5F1 stability
  • TRIM32 binds to the promoter region of SNCA, suggesting a novel mechanism of its transcriptional regulation
  • TRIM32 negatively regulates TLR3/4-mediated immune responses by targeting TICAM1 to TAX1BP1-mediated selective autophagic degradation
  • balanced ubiquitination and deubiquitination of MYC by TRIM32 and USP7 is a novel mechanism for stem cell fate determination
  • cell & other
    REGULATION
    induced by in myogenic differentiation
    repressed by IFN-gamma and LPS
    ASSOCIATED DISORDERS
    corresponding disease(s) LGMD2H , BBS11
    related resource Limb-Girdle Muscular Dystrophy pages
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    were detected in gastric cancer tissues
          --low  
    in atopic dermatitis skin compared with healthy control and psoriatic skin suggest a defective TRIM32 pathway in atopic dermatitis pathogenesis
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • TRIM32 expression levels may be of potential prognostic value in gastric cancer
  • Therapy target
    SystemTypeDisorderPubmed
    cancerhemopathy 
    potential therapeutic target for developmental disorders and RA-dependent leukemias
    neuromuscularmyopathy 
    is a possible therapeutic target to favor skeletal muscle regeneration in DMD patients
    ANIMAL & CELL MODELS
  • histological analysis of T32KO (Trim32 knock-out model) skeletal muscles revealed mild myopathic changes, electron microscopy showed areas with Z-line streaming and a dilated sarcotubular system with vacuoles -- the latter being a prominent feature of sarcotubular myopathy
  • Trim32-null mice showed a decrease in the concentration of neurofilament proteins in the brain and a reduced motoraxon diamete
  • Trim32-/- mice produced higher levels of serum inflammatory cytokines and were more sensitive to loss of body weight and inflammatory death upon Salmonella typhimurium infection